Suppr超能文献

通过自我互补腺相关病毒在小鼠视觉系统中诱导人ND4复合体I亚基的快速高效表达。

Induction of rapid and highly efficient expression of the human ND4 complex I subunit in the mouse visual system by self-complementary adeno-associated virus.

作者信息

Koilkonda Rajeshwari D, Chou Tsung-Han, Porciatti Vittorio, Hauswirth William W, Guy John

机构信息

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 1638 NW 10th Ave., Miami, FL 33136, USA.

出版信息

Arch Ophthalmol. 2010 Jul;128(7):876-83. doi: 10.1001/archophthalmol.2010.135.

Abstract

OBJECTIVE

To demonstrate the high efficiency and rapidity of allotopic expression of a normal human ND4 subunit of complex I in the vertebrate retina using a self-complementary adeno-associated virus (scAAV) vector for ocular gene delivery to treat acute visual loss in Leber hereditary optic neuropathy (LHON).

METHODS

The nuclear-encoded human ND4 subunit fused to the P1 isoform of subunit C of adenosine triphosphate synthase (ATPc) mitochondrial targeting sequence and FLAG epitope was packaged in scAAV2 capsids or single-stranded (ss) AAV2 capsids. These constructs were injected into the vitreous cavities of mice. The contralateral eyes were injected with scAAV-green fluorescent protein (GFP). One week later, pattern electroretinograms and gene expression of the human ND4 subunit and GFP were evaluated. Quantitative analysis of ND4FLAG-injected eyes was assessed relative to Thy1.2-labeled retinal ganglion cells (RGCs).

RESULTS

Pattern electroretinogram amplitudes remained normal in eyes inoculated with scAAV-ND4FLAG, ssAAV-ND4FLAG, and GFP. Confocal microscopy revealed the typical perinuclear mitochondrial expression of scAAV-ND4FLAG in almost the entire retinal flat mount. In contrast, scAAV-GFP expression was cytoplasmic and nuclear. Relative to Thy1.2-positive RGCs, quantification of scAAV-ND4FLAG-positive RGCs was 91% and that of ssAAV-ND4FLAG-positive RGCs was 51%.

CONCLUSION

Treatment of acute visual loss due to LHON may be possible with a normal human ND4 subunit gene of complex I, mutated in most cases of LHON, when delivered by an scAAV vector. Clinical Relevance Unlike most retinal degenerations that result in slowly progressive loss of vision over many years, LHON due to mutated mitochondrial DNA results in apoplectic, bilateral severe and usually irreversible visual loss. For rescue of acute visual loss in LHON, a highly efficient and rapid gene expression system is required.

摘要

目的

使用自我互补腺相关病毒(scAAV)载体进行眼部基因递送,以治疗Leber遗传性视神经病变(LHON)中的急性视力丧失,从而证明在脊椎动物视网膜中异位表达正常人类复合体I的ND4亚基的高效性和快速性。

方法

将与三磷酸腺苷合酶(ATPc)线粒体靶向序列的P1同工型和FLAG表位融合的核编码人类ND4亚基包装在scAAV2衣壳或单链(ss)AAV2衣壳中。将这些构建体注射到小鼠的玻璃体腔中。对侧眼注射scAAV-绿色荧光蛋白(GFP)。一周后,评估图形视网膜电图以及人类ND4亚基和GFP的基因表达。相对于Thy1.2标记的视网膜神经节细胞(RGC),对注射ND4FLAG的眼睛进行定量分析。

结果

接种scAAV-ND4FLAG、ssAAV-ND4FLAG和GFP的眼睛的图形视网膜电图振幅保持正常。共聚焦显微镜显示,在几乎整个视网膜平铺标本中,scAAV-ND4FLAG呈现典型的核周线粒体表达。相比之下,scAAV-GFP的表达是细胞质和细胞核的。相对于Thy1.2阳性RGC,scAAV-ND4FLAG阳性RGC的定量为91%,ssAAV-ND4FLAG阳性RGC的定量为51%。

结论

当通过scAAV载体递送时,大多数LHON病例中发生突变的复合体I的正常人类ND4亚基基因可能对治疗LHON引起的急性视力丧失有效。临床意义与大多数导致多年来视力缓慢进行性丧失的视网膜变性不同,由线粒体DNA突变引起的LHON会导致突发性、双侧严重且通常不可逆的视力丧失。为挽救LHON中的急性视力丧失,需要一种高效且快速的基因表达系统。

相似文献

2
Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system.
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4205-14. doi: 10.1167/iovs.08-3214. Epub 2009 Apr 22.
4
Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial.
JAMA Ophthalmol. 2014 Apr 1;132(4):409-20. doi: 10.1001/jamaophthalmol.2013.7630.
6
The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse.
Invest Ophthalmol Vis Sci. 2007 Jan;48(1):1-10. doi: 10.1167/iovs.06-0789.
9
Leber hereditary optic neuropathy gene therapy clinical trial recruitment: year 1.
Arch Ophthalmol. 2010 Sep;128(9):1129-35. doi: 10.1001/archophthalmol.2010.201.
10
Adeno-associated virus-mediated gene delivery of the human ND4 complex I subunit in rabbit eyes.
Clin Exp Ophthalmol. 2012 Dec;40(9):888-94. doi: 10.1111/j.1442-9071.2012.02815.x. Epub 2012 Jul 2.

引用本文的文献

1
A pilot study to determine the optimal dose of scAAVIL-1ra in a large animal model of post-traumatic osteoarthritis.
Gene Ther. 2023 Dec;30(12):792-800. doi: 10.1038/s41434-023-00420-2. Epub 2023 Sep 11.
2
3
Gene-agnostic approaches to treating inherited retinal degenerations.
Front Cell Dev Biol. 2023 Apr 13;11:1177838. doi: 10.3389/fcell.2023.1177838. eCollection 2023.
5
Leber Hereditary Optic Neuropathy: Molecular Pathophysiology and Updates on Gene Therapy.
Biomedicines. 2022 Aug 9;10(8):1930. doi: 10.3390/biomedicines10081930.
7
The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics.
Biomedicines. 2022 Feb 18;10(2):490. doi: 10.3390/biomedicines10020490.
8
Biodistribution of intravitreal nolparvovec gene therapy in nonhuman primates.
Mol Ther Methods Clin Dev. 2021 Oct 1;23:307-318. doi: 10.1016/j.omtm.2021.09.013. eCollection 2021 Dec 10.
9
Voretigene Neparvovec and Gene Therapy for Leber's Congenital Amaurosis: Review of Evidence to Date.
Appl Clin Genet. 2020 Nov 25;13:179-208. doi: 10.2147/TACG.S230720. eCollection 2020.
10
Therapeutic Options in Hereditary Optic Neuropathies.
Drugs. 2021 Jan;81(1):57-86. doi: 10.1007/s40265-020-01428-3.

本文引用的文献

1
Mitochondrial gene replacement in primate offspring and embryonic stem cells.
Nature. 2009 Sep 17;461(7262):367-72. doi: 10.1038/nature08368. Epub 2009 Aug 26.
2
Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system.
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4205-14. doi: 10.1167/iovs.08-3214. Epub 2009 Apr 22.
3
Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.
Hum Gene Ther. 2009 Aug;20(8):897-907. doi: 10.1089/hum.2009.023.
4
High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors.
Mol Ther. 2009 Mar;17(3):463-71. doi: 10.1038/mt.2008.269. Epub 2008 Dec 16.
7
Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction.
Am J Hum Genet. 2008 Sep;83(3):373-87. doi: 10.1016/j.ajhg.2008.08.013. Epub 2008 Sep 4.
8
Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.
Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7827-32. doi: 10.1073/pnas.0802866105. Epub 2008 May 29.
9
Safety and efficacy of gene transfer for Leber's congenital amaurosis.
N Engl J Med. 2008 May 22;358(21):2240-8. doi: 10.1056/NEJMoa0802315. Epub 2008 Apr 27.
10
Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
Gene Ther. 2008 Jun;15(11):808-16. doi: 10.1038/gt.2008.54. Epub 2008 Apr 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验